Displaying One Session

View
Room C Panel Discussion

Immuno-oncology endpoints for approval: The case of tumor agnostic approval for MSI-H cancers (ID 21)

Date
16.12.2018
Time
08:00 - 09:00
Location
Room C
Chairs
  • G. Coukos (Epalinges, Switzerland)
  • T. B. Powles (London, United Kingdom)
  • J. Tabernero (Barcelona, Spain)
Immuno-oncology endpoints for approval: The case of tumor agnostic approval for MSI-H cancers Panel Discussion

Session DOI (ID 524)

Lecture Time
08:00 - 08:00
Session Name
Immuno-oncology endpoints for approval: The case of tumor agnostic approval for MSI-H cancers
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
16.12.2018
Time
08:00 - 09:00
Immuno-oncology endpoints for approval: The case of tumor agnostic approval for MSI-H cancers Panel Discussion

The EMA position (ID 185)

Lecture Time
08:00 - 08:20
Speakers
  • F. Pignatti (London, United Kingdom)
Session Name
Immuno-oncology endpoints for approval: The case of tumor agnostic approval for MSI-H cancers
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
16.12.2018
Time
08:00 - 09:00
Authors
  • F. Pignatti (London, United Kingdom)
Immuno-oncology endpoints for approval: The case of tumor agnostic approval for MSI-H cancers Panel Discussion

Discussion led by Chairs (ID 187)

Lecture Time
08:20 - 09:00
Session Name
Immuno-oncology endpoints for approval: The case of tumor agnostic approval for MSI-H cancers
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
16.12.2018
Time
08:00 - 09:00